Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons

Journal of Neurochemistry

Volumn 77, Issue 5, 2001, Pages 1319-1326

  Hammond, Jennifer ^a   Le, Quynh ^b   Goodyer, Cynthia ^b   Gelfand, Morrie ^b   Trifiro, Mark ^b   LeBlanc, Andrea ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Androgen; Apoptosis; Estrogen; Human primary neurons

Indexed keywords

ANDROGEN RECEPTOR; EPITESTOSTERONE; ESTRADIOL; ESTROGEN; FLUTAMIDE; METHYLTESTOSTERONE; MIBOLERONE; TESTOSTERONE;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FETUS; HUMAN; HUMAN TISSUE; NERVE CELL CULTURE; NEUROPROTECTION; PRIORITY JOURNAL;

ANDROGEN ANTAGONISTS; APOPTOSIS; AROMATASE INHIBITORS; BRAIN; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENZYME INHIBITORS; ESTROGENS; FLUTAMIDE; HUMANS; IN SITU NICK-END LABELING; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 0035006622     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00345.x     Document Type: Article

References (65)

1. New Insights into the regulation and function of brain estrogen synthase (aromatase)
2. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
3. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
4. 17 β-estradiol enhances the outgrowth and survival of neocortical neurons in culture
5. Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer
6. Immunocytochemical labeling of androgen receptors in the brain of rat and monkey
7. Androgen replacement in women: A commentary
8. Testosterone propionate administration prevents the loss of neurons within the central part of the medial preoptic nucleus
9. Estradiol modulates Bcl-2 in cerebral ischemia: A potential role for estrogen receptors
10. Comparative studies of the aromatization of testosterone and epitestosterone by human placental aromatase
11. Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex
12. Age-related decrease of plasma testosterone in SAMP8 Mice: Replacement improves age-related Impairment of learning and memory
13. Estrogen-androgen hormone replacement therapy
14. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity
15. Testosterone reduces neuronal secretion of Alhzeimer's β-amyloid peptides
16. Neuroprotective effects of estrogens: Potential mechanisms of action
17. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells
18. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein
19. The Prevalence of dementia: A quantitative integration of the literature
20. Kinetic evidence for a unique testosterone-receptor complex in 5α-reductase sufficient genital skin fibroblasts and the effects of 5α-reductase deficiency on its formation
21. Mechanism of action and pure antiandrogenic properties of flutamide
22. Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: Possible involvement of apoptosis
23. Protein replacement with the Folin phenol reagent
24. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain
25. Inhibition of dendritic spine induction on hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist in female rats
26. Effects and metabolism of steroid hormones in human neuroblastoma cells
27. Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays
28. Epidemiology of dementia in a Finnish population
29. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
30. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease
31. Clinical applications of antiandrogens
32. Epitestosterone: A potential new antiandrogen
33. Oestrogen replacement therapy and Alzheimer's disease
34. Estrogen Modulates Neuronal Bcl-x expression and β-Amyloid-Induced Apoptosis: Relevance to Alzheimer's Disease
35. Immunocytochemical detection of androgen receptor in human temporal cortex: Characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues
36. Testosterone deficiency: A key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging
37. Effects of estrogen replacement therapy on response totacrine in patients with Alzheimer's disease
38. Potential role for estrogen replacement in the treatment of Alzheimer's dementia
39. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
40. The role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's
41. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways
42. Androgen receptor antagonists (antiandrogens): Structure-activity relationships
43. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock out mice
44. Epitestosterone - An endogenous antiandrogen?
45. Observations on the biological activity of epitestosterone
46. Age-associated testosterone decline in men: Clinical issues for psychiatry
47. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease
48. High-dose anabolic steroids modulate concentration of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain
49. Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus
50. Estrogen as a treatment for Alzheimer disease
51. Novel sites and mechanisms of oestrogen action in the brain
52. Binding of 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues
53. Androgen binding as evidenced by a whole cell assay system using cultured canine prostatic epithelial cells
54. Androgens in the aging male
55. Overlapping and divergent actions of estrogen and the neurotrophins on cell fate and p53-dependent signal transduction in conditionally immortalized cerebral cortical neuroblasts
56. Binding of 17-alpha-methyltestosterone in vitro to human sex hormone binding globulin and rat ventral prostate androgen receptors
57. Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate
58. Effects of estrogen in the CNS
59. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat
60. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism
61. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density
62. Familial Alzheimer's disease - Beta-amyloid resurrected
63. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
64. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, 6, 7 and 8